STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW HETEROCYCLE-CONTAINING BISPHOSPHONATES AS INHIBITORS OF BONE-RESORPTION AND AS INHIBITORS OF GROWTHOF DICTYOSTELIUM-DISCOIDEUM AMEBAS
Mj. Rogers et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW HETEROCYCLE-CONTAINING BISPHOSPHONATES AS INHIBITORS OF BONE-RESORPTION AND AS INHIBITORS OF GROWTHOF DICTYOSTELIUM-DISCOIDEUM AMEBAS, Molecular pharmacology, 47(2), 1995, pp. 398-402
The mechanisms by which bisphosphonate drugs inhibit osteoclast-mediat
ed bone resorption are unclear. Effects of bisphosphonates on cellular
enzymes, metabolic pathways, and osteoclast morphology have previousl
y been described and could culminate in a generalized cytotoxic effect
or a decreased capacity of osteoclasts to resorb bone. Recent studies
of the structure-activity relationship for the bisphosphonate side ch
ain indicate, however, that at least the newer generations of nitrogen
-containing bisphosphonates probably act by binding to a specific targ
et at a site that is complementary in structure to the bisphosphonate
side chain. We have previously proposed that such a target for bisphos
phonates is also present in amoebae of the cellular slime mold Dictyos
telium discoideum, because growth of this microorganism is inhibited b
y a wide range of bisphosphonates in a manner that closely reflects th
e antiresorptive potencies of the bisphosphonates in vivo, We have add
ed support for this view by examining the potency towards Dictyosteliu
m of bisphosphonates in which slight changes in the structure of the s
ide chain or conformational restrictions to the side chain have marked
effects on antiresorptive potency. The changes in the side chain that
affected the in vivo antiresorptive potency of the bisphosphonates co
nsistently affected in a similar manner the potency of the bisphosphon
ates as inhibitors of the growth of Dictyostelium amoebae. These obser
vations confirm that bisphosphonate drugs have a molecular target that
is common to both Dictyostelium amoebae and osteoclasts.